Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,122 total articles

Core & Main Director James Hope Acquires $95,110 in Company Stock

Core & Main Director James Hope Acquires $95,110 in Company Stock

Core & Main, Inc. (NYSE: CNM) has disclosed a recent equity transaction involving its director, James D. Hope. The filing indicates a direct purchase of Class A Common Stock, bringing his total direct holdings to 11,805 shares. This transaction occurs against a backdrop of significant corporate financial restructuring, including the pricing of new …

Silver Lake Affiliates Liquidate $578k Dell Holdings Amidst Valuation Debates and AI Infrastructure Push

Silver Lake Affiliates Liquidate $578k Dell Holdings Amidst Valuation Debates and AI Infrastructure Push

Silver Lake Technology Investors IV, L.P., a key affiliate of private equity firm Silver Lake, has executed a series of transactions involving Dell Technologies Inc. (NYSE:DELL), resulting in the sale of 1,409 shares of Class C Common Stock. The divestment, valued at approximately $578,426, occurred against a backdrop of significant stock appreciat…

Ibotta: Clark Jermoluk Founders Fund I Sells $15.1M in Stock

Ibotta: Clark Jermoluk Founders Fund I Sells $15.1M in Stock

Clark Jermoluk Founders Fund I LLC, a significant ten percent shareholder in Ibotta, Inc. (NASDAQ:IBTA), executed a substantial divestment of its holdings in early July 2026. The fund sold 500,000 shares of Ibotta's Class A Common Stock on July 6, 2026, at an average price of $30.15 per share. This transaction resulted in a total realized value of …

Mirum Pharmaceuticals CEO Christopher Peetz Executes $2.4 Million Stock Sale Under Pre-Arranged Plan

Mirum Pharmaceuticals CEO Christopher Peetz Executes $2.4 Million Stock Sale Under Pre-Arranged Plan

Mirum Pharmaceuticals CEO Christopher Peetz sold 20,000 shares for approximately $2.4 million following the exercise of employee stock options. The transactions, executed under a Rule 10b5-1 plan, occurred as the stock trades near its 52-week high. Peetz retains significant holdings through direct and trust accounts. Recent company developments inc…

EverQuote Executive Activity and Valuation Dynamics

EverQuote Executive Activity and Valuation Dynamics

Jon Ayotte, EverQuote's Chief Accounting Officer, executed a series of transactions in early July 2026 under a pre-existing Rule 10b5-1 plan, selling 881 shares while simultaneously exercising options to acquire 3,156 shares. These moves occur against a backdrop of robust Q1 2026 financial performance that beat consensus estimates on both earnings …

Charles Schwab Executive Sells Shares Under Pre-Arranged Plan

Charles Schwab Executive Sells Shares Under Pre-Arranged Plan

Jonathan S. Beatty, MD and Head of Advisor Services at Charles Schwab Corp (NYSE:SCHW), executed a sale of 2,000 shares on July 7, 2026, totaling $204,017. The transaction was conducted under a Rule 10b5-1 trading plan adopted earlier in the year, with shares sold at prices between $102.00 and $102.025 per share. This sale occurred as the stock tra…